MedPath

Clinical trial to mineral absorption effect of test food

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000052020
Lead Sponsor
EP Mediate Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects 1.who undergoing hormone replacement therapy 2.who have a disease that is being treated or who have a disease that is deemed to require treatment 3.who are undergoing medical treatment or have a medical history of malignant tumor, heart failure or myocardial kidney disease etc. infarction 4.who regularly use related to lactic acid bacteria, vitamins, and minerals, health foods, pharmaceuticals, quasi-drugs, over-the-counter drugs, nutritional supplements, and minerals and continue to take them during the study period 5.who regularly use health foods or medicines that promote or inhibit the absorption of calcium, magnesium, and iron 6.who routinely consume foods fortified with calcium, magnesium, and iron 7. who regularly use pharmaceuticals 8.who have a tendency toward diarrhea 9.who have been diagnosed with hyperhidrosis or who are aware of hyperhidrosis 10.who tend to urinate frequently or who urinate extremely infrequently 11.who have possibilities for emerging allergy onset food allergies 12. who regularly engaged in exercise or activities that involve excessive sweating 13.who have physical labor in perspiration 14.who night and day shift worker or manual laborer 15.women with irregular menstruation 16.who drink a lot 17.who with an unbalanced diet or those with irregular eating habits 18.who cannot control their room temperature 19.who cannot drink the prescribed amount of water on the day of the examination 20.who are judged as unsuitable due to lifestyle questionnaire 21.who are judged as unsuitable for the study based on the results of clinical and physical examination screening test 22.who have participated in other clinical study within three months before the screening test or who intend to participate in the study period 23.who are planned to become pregnant or are pregnant or lactating 24.who are judged as unsuitable for the study by the investigator for other reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath